The activity of a key mitochondrial tricarboxylic acid cycle enzyme, α-ketoglutarate dehydrogenase complex (KGDHC), declines in many neurodegenerative diseases. KGDHC consists of three subunits. The dihydrolipoyl succinyl transferase (DLST) component is unique to KGDHC. DLST +/− mice showed reduced mRNA and protein levels and decreased brain mitochondrial KGDHC activity. Neurotoxic effects of mitochondrial toxins were exacerbated in DLST +/− mice. MPTP produced a significantly greater reduction of striatal dopamine and tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta of DLST +/− mice. DLST deficiency enhanced the severity of lipid peroxidation in the substantia nigra after MPTP treatment. Striatal lesions induced by either malonate or 3-nitropropionic acid (3-NP) were significantly larger in DLST +/− mice than in wildtype controls. DLST deficiency enhanced the 3-NP inhibition of mitochondria enzymes, and 3-NP induced protein and DNA oxidations. These observations support the hypothesis that reductions in KGDHC may impair the adaptability of the brain and contribute to the pathogenesis of neurodegenerative diseases.
The α-ketoglutarate dehydrogenase complex (KGDHC) is a mitochondrial enzyme that plays an important role in brain metabolism. KGDHC is crucial in the cellular production of reducing equivalents (NADH) and in the maintenance of the mitochondrial redox state of the brain (Gibson et al., 2000a) . There is burgeoning evidence that KGDHC may be involved in the pathophysiology of multiple neurodegenerative diseases. Reductions in KGDHC activity have been reported in Alzheimer's disease (AD) (Gibson et al., 1988 ), Huntington's disease (HD) (Klivenyi et al., 2004 ), Parkinson's disease (PD) (Mizuno et al., 1990; Mizuno et al., 1994; Mizuno et al., 1995; Gibson et al., 2003) , Progressive Supranuclear Palsy (PSP) (Park et al., 2001 ) and spinocerebellar ataxia (Mastrogiacomo and Kish 1994) . Diminished KGDHC activity occurs in both normal and pathologically involved brain areas of patients with a number of neurodegenerative diseases including AD (Gibson et al., 1988; Gibson et al., 2003) . The reduction in KGDHC activity is highly correlated to the clinical dementia rating of AD patients (Gibson et al., 2000b; Bubber et al., 2005) . These results suggest that KGDHC may play a central role in the pathophysiology of neurodegenerative diseases. Oxidative stress, a common feature of these neurodegenerative diseases, is known to inactivate KGDHC (Park et al., 1999) .
KGDHC consists of 3 protein subunits, namely α-ketoglutarate dehydrogenase (E1k; E.C. 1.2.4.2 encoded by the ogdh gene), dihydrolipoyl succinyl transferase (DLST; E.C. 2.3.1.61 encoded by the dlst gene) and dihydrolipoamide dehydrogenase (DLD; E.C. 1.8.1.4 encoded by the dld gene). KGDHC is a member of the KGDHC complex family. This family also includes the pyruvate dehydrogenase complex (PDHC) and the branched chain α-ketoacid dehydrogenase complex. A subunit contained in all of these dehydrogenases is dihydrolipoamide dehydrogenase (DLD), which is also known as E3, a critical subunit shared by all three dehydrogenases. It is a flavin-containing protein that transfers reducing equivalents from a dihydrolyl moiety to NAD + to form NADH and complete the catalytic process of the complex. OGDH and DLST are unique to KGDHC. Encoded by the dlst gene, DLST catalyzes an important reaction sequence in α-ketoacid
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Abbreviations: DLST, dihydrolipoyl succinyl transferase; DLD, dihydrolipoamide dehydrogenase; OGDH, α-ketoglutarate dehydrogenase; KGDHC, α-ketoglutarate dehydrogenase complex; AD, Alzheimer's disease; HD, Huntington's disease; PD, Parkinson's disease; 8OH2dG, 8-hydroxy-2-deoxyguanosine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PDHC, pyruvate dehydrogenase complex; C-I, respiratory chain Complex I; COX, cytochrome oxidase; MDH, malate dehydrogenase; CS, citrate synthase; ME, malic enzyme (NADPH); SDH, succinate dehydrogenase; GR, glutathione reductase; GPx1, mitochondrial glutathione peroxidase 1; MnSOD, mitochondrial manganese superoxide dismutase; TCA, tricarboxlyic acid cycle.
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